Stopped: The study was not funded.
This project is being completed to test the usability and safety of the Watch-Transcutaneous Electrical Acustimulation (TEA) Device. This is a pilot study that will lead to future projects for cancer patients that may experience chemotherapy-induced symptoms.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Usability of the device for both groups day 3
Timeframe: Day 3
Number of adverse events related to the device noted on the safety questionnaire
Timeframe: 1-2 weeks (after baseline visit 1)
Number of Transcutaneous Electrical Acustimulation (TEA)-related adverse events for both groups 3 days
Timeframe: Day 3
Number of TEA-related adverse events for both groups 60 minutes at maximal tolerable level
Timeframe: Daily for 3 days
Number of non-treatment TEA adverse events for both groups
Timeframe: up to 1-2 weeks (after baseline visit 1)